Those data were completed by fluorescence microscopy assessment showing the increased numbers and the distribution of CD25+NK (Figure S1) and CD69+NK cells (Figure S2) in the tumour site after ITPP treatment with reference to the CD31+ vessels and confirmed by immunohistochemical detection of the CD49b+ NK cells upon such treatment (Figure S3). The gene discussed is CD69; the disease is neoplasm.